The Principles of Clinical Cytogenetics - Extra Materials - Springer

360 Xiao-Xiang Zhang
REFERENCES
1. Langauer, C., Kinzler, K.W., and Vogelstain, B. (1998) Genetic instabilities in human cancers. Nature 396, 643–649.
2. Hittelman, W.N. (2001) Genetic instability in epithelial tissues at risk for cancer. Ann. NY Acad. Sci. 952, 1–12.
3. Smith, D.I., Huang, H., and Wang, L. (1998) Common fragile sites and cancer. Int. J. Oncol. 12, 187–196 (review).
4. Sutherland, G.R. and Mattei, J.F. (1987) Report of the committee on cytogenetic markers. Cytogenet. Cell Genet. 46,
316–324.
5. Simonic, I. and Gericke, G.S. (1996) The enigma of common fragile sites. Hum. Genet. 97, 524–531.
6. Hecht, F.H., Ramesh, K.H., and Lockwood, D.H. (1990) A guide to fragile sites on human chromosomes. Cancer
Genet. Cytogenet. 44, 37–45.
7. Genome Data Base (GDB); available at www.gdb.org.
8. Smeets, D.F. and van de Klundert, F.A. (1990) Common fragile sites in man and three closely related primate species.
Cytogenet. Cell Genet. 53, 8–14.
9. Sutherland, G.R. and Richards, R. (1999) Human Genetics ’99: Trinucleotide Repeats. Fragile sites—cytogenetic similarity
with molecular diversity. Am. J. Hum. Genet. 64, 354–359.
10. Le Beau, M.M., Rassool, F.V., Neilly, M.E., et al. (1998) Replication of a common fragile site, FRA3B, occurs late in
S phase and is delayed further upon induction: implications for the mechanism of fragile site induction. Hum. Mol.
Genet. 7, 755–761.
11. Jones, C., Mullenbach, R., Grossfeld, P., et al. (2000) Co-localization of CCG repeats and chromosome deletion
breakpoints in Jacobsen syndrome: evidence for a common mechanism of chromosome breakage. Hum. Mol. Genet. 9,
1201–1208.
12. Mariani, T., Musio, A., and Simi, S. (1995) No statistics association between fragile sites and constitutional chromosome
breakpoints. Cancer Genet. Cytogenet. 85, 78–81.
13. Kahkonen, M., Tengstrom, C., Alitalo, T., Matilainen, R., Kaski, M., and Airaksinen, E. (1989) Population cytogenetics
of folate-sensitive fragile sites. II. Autosomal rare fragile sites. Hum. Genet. 82, 3–8.
14. Yunis, J.J. and Soreng, A.L. (1984) Constitutive fragile sites and cancer. Science 226, 1199–1204.
15. Gumus, G., Sunguroglu, A., Tukun, A., Sayin, D.B., and Bokesy, I. (2002) Common fragile sites associated with the
breakpoints of chromosomal aberrations in hematologic neoplasms. Cancer Genet. Cytogenet. 133, 168–171.
16. Wilke, C.M., Hall, B.K., Hoge, A., Paradee, W., Smith, D.I., and Glover, T.W. (1996) FRA3B extends over a broad
region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites
and fragile sites. Hum. Mol. Genet. 5, 187–195.
17. Hellman, A., Zlotorynski, E., Scherer, S.W., et al. (2002) A role for common fragile site induction in amplification of
human oncogenes. Cancer Cell 1, 89–97.
18. Coquelle, A., Pipiras, E., Toledo, F., Buttin, G., and Debatisse, M. (1997) Expression of fragile sites triggers
intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89, 215–225.
19. Egeli, U., Karadag, M., Tunca, B., and Ozyardimci, N. (1997) The expression of common fragile sites and genetic
predisposition to squamous cell lung cancers. Cancer Genet. Cytogenet. 95, 153–158.
20. Sutherland, G.R. and Baker, E. (2000) The clinical significance of fragile sites on human chromosomes. Clin. Genet.
58, 157–161.
21. Auerbach, A.D. (1992) Fanconi anemia and leukemia: tracking the genes. Leukemia 6(Suppl. 1), 1–4.
22. Joenje, H. and Patel, K.J. (2001) The emerging genetic and molecular basis of Fanconi anemia. Nature Rev. 2, 446–457.
23. Auerbach, A.D., Buchwald, M., and Joenje, H. (2001) Fanconi Anemia. In The Metabolic and Molecular Bases of
Inherited Disease (Scriver, C., Beaudet, A., Sly, W., Valle, D., Childs, B., Kinzler, K., and Vogelstein, B., eds.),
McGraw-Hill, New York, pp. 753–768.
24. Wijker, M., Morgan, N .V., Herterich, S., et al. (1999) Heterogeneous spectrum of mutations in the Fanconi anemia
group A gene. Eur. J. Hum. Genet. 7, 52–59.
25. Faivre, L., Guardiola, P., Lewis, C., et al. (2000) Association of complementation group and mutation type with clinical
outcome in Fanconi anemia. Blood 96, 4064–4070.
26. Callen, E., Samper, E., Ramirez, M.J., et al. (2002) Breaks at telomeres and TRF2-independent end fusions in Fanconi
anemia. Hum. Mol. Genet. 11, 439–444.
27. Gatti, R.A., Boder, E., Vinters, H.V., Sparkes, R.S., Norman, A., and Lange, K. (1991) Ataxia-telangiectasia: an interdisciplinary
approach to pathogenesis. Medicine 70, 99–117.
28. Swift, M., Morrell, D., Cromartie, E., Chamberlin, A.R., Skolnick, M.H., and Bishop, D.T. (1986) The incidence and
gene frequency of ataxia-telangiectasia in the United States. Am. J. Hum. Genet. 39, 573–583.
29. Swift, M., Morrell, D., Massey, R.B., and Chase, C.L. (1991) Incidence of cancer in 161 families affected by ataxiatelangiectasia.
N. Engl. J. Med. 325, 1831–1836.
30. Concannon, P. and Gatti, R.A. (1997) Diversity of ATM gene mutations detected in patients with ataxia-telangiectasia.
Hum. Mutat. 10, 100–107.
31. Gilad, S., Bar-Shira, A., Harnik, R., et al. (1996) Ataxia-telangiectasia: founder effect among North African Jews.
Hum. Mol. Genet. 5, 2033–2037.